133 related articles for article (PubMed ID: 31264934)
21. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
22. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
23. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
Constantinou P; Dray-Spira R; Menvielle G
BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
[TBL] [Abstract][Full Text] [Related]
24. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
25. The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).
Whop LJ; Garvey G; Baade P; Cunningham J; Lokuge K; Brotherton JM; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig D; Moore SP; Condon JR
Cancer; 2016 May; 122(10):1560-9. PubMed ID: 27149550
[TBL] [Abstract][Full Text] [Related]
26. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening behaviors and proximity to federally qualified health centers in South Carolina.
Adams SA; Haynes VE; Brandt HM; Choi SK; Young V; Eberth JM; Hébert JR; Friedman DB
Cancer Epidemiol; 2020 Apr; 65():101681. PubMed ID: 32035294
[TBL] [Abstract][Full Text] [Related]
28. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
Zhang D; Advani S; Huchko M; Braithwaite D
BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
[TBL] [Abstract][Full Text] [Related]
29. Australian women's cervical cancer screening attendance as a function of screening barriers and facilitators.
Brown RF; Muller TR; Olsen A
Soc Sci Med; 2019 Jan; 220():396-402. PubMed ID: 30529797
[TBL] [Abstract][Full Text] [Related]
30. Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas.
Thompson B; Carosso EA; Jhingan E; Wang L; Holte SE; Byrd TL; Benavides MC; Lopez C; Martinez-Gutierrez J; Ibarra G; Gonzalez VJ; Gonzalez NE; Duggan CR
Cancer; 2017 Feb; 123(4):666-674. PubMed ID: 27787893
[TBL] [Abstract][Full Text] [Related]
31. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
32. Predictors of cervical cancer screening uptake in two districts of Central Uganda.
Isabirye A; Mbonye MK; Kwagala B
PLoS One; 2020; 15(12):e0243281. PubMed ID: 33270792
[TBL] [Abstract][Full Text] [Related]
33. Cervical Cancer Screening in Women With Severe Mental Disorders: An Approach to the Spanish Context.
Borrull-Guardeño J; Domínguez A; Merizalde-Torres MH; Sánchez-Martínez V
Cancer Nurs; 2019; 42(4):E31-E35. PubMed ID: 29677009
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with cervical cancer screening among young unmarried Japanese women: results from an internet-based survey.
Kaneko N
BMC Womens Health; 2018 Jul; 18(1):132. PubMed ID: 30064505
[TBL] [Abstract][Full Text] [Related]
35. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
36. Using Evidence-Based Interventions to Improve Cancer Screening in the National Breast and Cervical Cancer Early Detection Program.
DeGroff A; Carter A; Kenney K; Myles Z; Melillo S; Royalty J; Rice K; Gressard L; Miller JW
J Public Health Manag Pract; 2016; 22(5):442-9. PubMed ID: 26672405
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A; van Niekerk D; Smith L; Ogilvie G
J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
[TBL] [Abstract][Full Text] [Related]
38. The role of health education on cervical cancer screening uptake at selected health centers in Addis Ababa.
Abu SH; Woldehanna BT; Nida ET; Tilahun AW; Gebremariam MY; Sisay MM
PLoS One; 2020; 15(10):e0239580. PubMed ID: 33027267
[TBL] [Abstract][Full Text] [Related]
39. [Interval between two smear tests for cervical cancer screening and characteristics of women with a short interval: Study in the department of Isère].
Caporossi A; Olicard C; Seigneurin A; Garnier A
Rev Epidemiol Sante Publique; 2019 May; 67(3):143-147. PubMed ID: 30981595
[TBL] [Abstract][Full Text] [Related]
40. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
